Resultados de la búsqueda 1-10 of 10827 for Acute lymphadenitis

  1. Linfadenitis mesentérica - Diagnóstico y tratamiento - Mayo Clinic

    Acute mesenteric lymphadenitis in children: Findings related to differential diagnosis and hospitalization. Archives of Medical Science. 2020; doi:10.5114 ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  3. Médicos y departamentos

    Lymphadenopathy. Merck Manual Professional Version. https://www ... Lymphangitis and lymphadenitis. In: Current Medical Diagnosis & Treatment ...

  4. Médicos y departamentos

    Lymphadenopathy. Merck Manual Professional Version. https://www ... Lymphangitis and lymphadenitis. In: Current Medical Diagnosis & Treatment ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The Effects Of Acute And Chronic Exercise On Immune Phenotype Of Indolent Non-Hodgkin Lymphoma And Chronic Lymphocytic Leukemia Patients. Rochester, Minn ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The Effects Of Acute And Chronic Exercise On Immune Phenotype Of Indolent Non-Hodgkin Lymphoma And Chronic Lymphocytic Leukemia Patients. Rochester, Minn ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...